| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |